BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Society of Cannabis Clinicians - ECPv6.15.15//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Society of Cannabis Clinicians
X-ORIGINAL-URL:https://www.cannabisclinicians.org
X-WR-CALDESC:Events for Society of Cannabis Clinicians
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20230312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20231105T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20240310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20241103T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Australia/Sydney
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20210403T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20211002T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20220402T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20221001T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20230401T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20230930T160000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20230607T090000
DTEND;TZID=America/Los_Angeles:20230607T100000
DTSTAMP:20260607T072511
CREATED:20230316T112915Z
LAST-MODIFIED:20230324T102621Z
UID:10000139-1686128400-1686132000@www.cannabisclinicians.org
SUMMARY:SCC and Csequence Journal Club Presents: Mark Viner\, MD on State Cannabis Legalization and Psychosis-Related Health Care Utilization
DESCRIPTION:This Journal Club series hosts monthly educational events where authors discuss their newly published scientific findings. Presentations will focus on a variety of articles and perspectives related to cannabis medicine\, including but not limited to clinically-relevant articles and research methodology-focused papers. \nThis month’s installment will hear Dr. Mark Viner discuss the recently published article\, State Cannabis Legalization and Psychosis-Related Health Care Utilization. \nRegister
URL:https://www.cannabisclinicians.org/event/scc-and-csequence-journal-club-presents-mark-viner-md-on-state-cannabis-legalization-and-psychosis-related-health-care-utilization/
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2023/03/MJC-June-7-2023-with-Mark-Viner.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20230526T090000
DTEND;TZID=America/Los_Angeles:20230526T100000
DTSTAMP:20260607T072512
CREATED:20230316T112612Z
LAST-MODIFIED:20230316T130033Z
UID:10000138-1685091600-1685095200@www.cannabisclinicians.org
SUMMARY:Quarterly Meeting: Featuring Douglas Bruce\, PhD\, MSW on Cannabis & HIV
DESCRIPTION:Join us for a special Quarterly Meeting featuring Dr. Douglas Bruce on the topic of: The spectrum of cannabis use among young persons living with HIV/AIDS. \nDouglas Bruce\, PhD\, MSW is a public health researcher and earned his PhD in public health from the University of Illinois at Chicago. His mixed methods research focuses on the health behavior of persons living with chronic conditions\, including the secondary prevention needs of young persons living with HIV/AIDS\, and the role of cannabis in the lives of persons living with chronic disease. He has served as principal investigator on grants from the National Institute on Drug Abuse\, the National Institute of Mental Health\, and the National Institute of Child Health and Human Development. As a program evaluation and development consultant\, Dr. Bruce has worked with a number of local organizations\, such as the AIDS Foundation of Chicago and Chicago Department of Public Health\, as well as national and international organizations\, including the Centers for Disease Control and Prevention and the US Agency for International Development. \nRegister
URL:https://www.cannabisclinicians.org/event/quarterly-meeting-featuring-douglas-bruce-phd-msw-on-cannabis-hiv/
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2023/03/QM-May-27th-with-Dr.-Douglas-Bruce-1-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20230515T080000
DTEND;TZID=America/Los_Angeles:20230515T100000
DTSTAMP:20260607T072512
CREATED:20230123T152701Z
LAST-MODIFIED:20230316T105238Z
UID:10000129-1684137600-1684144800@www.cannabisclinicians.org
SUMMARY:CannMed Medical Practicum
DESCRIPTION:This workshop is for clinicians exploring the therapeutic potential of medicinal plants\, or laypersons looking to understand these medicines at a clinical level. It begins with an exploration of the human endocannabinoid system\, and takes a deep dive into how these plants work to alleviate a host of conditions\, including dosing\, safety\, efficacy\, side effects\, and more. Full day with CME and CEU credits available. We are proud to announce that all of the practicum speakers are long-time members of the SCC. \nRegister
URL:https://www.cannabisclinicians.org/event/cannmed-medical-practicum/
LOCATION:Marco Island\, FL\, Marco Island\, FL\, United States
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2023/01/Practicum-Rec-Img-.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20230510T090000
DTEND;TZID=America/Los_Angeles:20230510T100000
DTSTAMP:20260607T072512
CREATED:20230316T111153Z
LAST-MODIFIED:20230324T102541Z
UID:10000137-1683709200-1683712800@www.cannabisclinicians.org
SUMMARY:Book Launch with Peter Grinspoon\, MD -- Seeing through the Smoke: A Cannabis Specialist Untangles the Truth about Marijuana
DESCRIPTION:This edition of the SCC / Csequence Journal Club will feature Peter Grinspoon\, MD as he discusses his new book (available on April 20\, 2023). \nYou can pre-order the book here. \nDescription: \nDepending on which doctor you speak with\, or which websites you read\, cannabis could be an appealing\, low-risk medicine – even an aid to wellness – or an insidiously addictive drug rotting the brains of our youth. This dissonance confuses young people\, distressed patients\, and paralyzes politicians\, all while inviting dubious sources of information and resulting in uninformed choices\, enhanced polarization\, and a fragmented national policy. \nSeeing Through the Smoke is an unflinching examination at the grossly misunderstood drug that uses data-driven medical science and a critical historical perspective to reveal the truth behind cannabis. In this balanced and measured investigation\, Cannabis specialist and Instructor in Medicine at Harvard Medical School Dr. Peter Grinspoon untangles the reality behind cannabis\, revealing how we ended up with radically divergent understandings of the drug and pointing a way toward a middle ground that we can all share. \nMoving through an illuminating tour of the social history and the medical science behind cannabis\, Grinspoon unpacks the layers of disinformation left by a sordid history of government propaganda\, racial suppression\, and indifference from the medical community to answer questions like: \n\nIs cannabis addictive?\nWhat are its best-established medical uses?\nCan cannabis help cure cancer?\nHow does cannabis affect memory?\nHow dangerous is cannabis for teens?\nIs cannabis a safer treatment for ADHD and PTSD?\nWhat exactly is CBD and how is it different from marijuana?\nWhat are the most concerning side effects?\n\nBy focusing on the most critical purported harms—driving\, pregnancy\, addictiveness\, memory—and by focusing on the most commonly cited medical benefits—relieving chronic pain\, sleep\, anxiety\, PTSD\, autism\, and cancer—Seeing Through the Smoke will help patients\, parents\, doctors\, health experts\, regulators\, and politicians move beyond biased perceptions and arrive at a shared reality towards cannabis. \nRegister
URL:https://www.cannabisclinicians.org/event/book-launch-with-peter-grinspoon-md-seeing-through-the-smoke-a-cannabis-specialist-untangles-the-truth-about-marijuana/
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2023/03/MJC-May-10-2023-with-Dr.-Grinspoon.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20230428T090000
DTEND;TZID=America/Los_Angeles:20230428T100000
DTSTAMP:20260607T072512
CREATED:20230315T133550Z
LAST-MODIFIED:20230324T102405Z
UID:10000135-1682672400-1682676000@www.cannabisclinicians.org
SUMMARY:Special Presentation: Fred Gardner & Dr. Jeffrey Hergenrather on the History of SCC
DESCRIPTION:Join us for this Special Presentation with Fred Gardner and Dr. Jeffrey Hergenrather as they recount pivotal moments in California’s medical cannabis movement — Proposition 215\, Dr. Tod Mikuriya\, and the formation of the California Cannabis Research Medical Group (CCRMG) / Society of Cannabis Clinicians. \nRegister
URL:https://www.cannabisclinicians.org/event/special-presentation-fred-gardner-dr-jeffrey-hergenrather-on-the-history-of-scc/
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2023/03/Special-Presentation-on-The-History-of-SCC-2-April-28-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20230420T090000
DTEND;TZID=America/Los_Angeles:20230420T100000
DTSTAMP:20260607T072512
CREATED:20230315T133413Z
LAST-MODIFIED:20230324T104100Z
UID:10000134-1681981200-1681984800@www.cannabisclinicians.org
SUMMARY:Roundtable Discussion on the New Certification in Basic Cannabinoid Medicine
DESCRIPTION:Register
URL:https://www.cannabisclinicians.org/event/roundtable-discussion-on-the-new-certification-in-basic-cannabinoid-medicine/
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2023/03/Certificate-in-BCM-1-1-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20230405T090000
DTEND;TZID=America/Los_Angeles:20230405T100000
DTSTAMP:20260607T072512
CREATED:20230315T133055Z
LAST-MODIFIED:20230324T102243Z
UID:10000133-1680685200-1680688800@www.cannabisclinicians.org
SUMMARY:SCC and Csequence Journal Club Presents: Adam Abodeely\, MD\, MBA on Cannabinoids & Gastrointestinal Ailments
DESCRIPTION:This Journal Club series hosts monthly educational events where authors discuss their newly published scientific findings. Presentations will focus on a variety of articles and perspectives related to cannabis medicine\, including but not limited to clinically-relevant articles and research methodology-focused papers. \nThis month’s installment will hear Dr. Adam Abodeely discuss his research on cannabinoids & gastrointestinal ailments. \nArticle:\nThe minor cannabinoids and their potential implications for conditions of the gastrointestinal system \nRegister
URL:https://www.cannabisclinicians.org/event/scc-and-csequence-journal-club-presents-adam-abodeely-md-mba-on-cannabinoids-gastrointestinal-ailments/
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2023/03/MJC-April-5-2023-with-Adam-Abodeely.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20230330T083000
DTEND;TZID=America/Los_Angeles:20230330T093000
DTSTAMP:20260607T072512
CREATED:20230316T105022Z
LAST-MODIFIED:20230316T105022Z
UID:10000136-1680165000-1680168600@www.cannabisclinicians.org
SUMMARY:International Committee: Cannabis in Thailand by Dr. Shiksha Gallow
DESCRIPTION:Dr. Shiksha Gallow presents to the SCC International Committee an update on Medical Cannabis in Thailand. Join us on Thursday\, March 30th to hear all of the need to know information on what is happening politically in the Thailand medical cannabis movement\, and where clinicians’ rights to practice cannabis medicine stand. \nThis is a SCC Members Only event. Must log in to your SCC account to register. \nRegister
URL:https://www.cannabisclinicians.org/event/international-committee-cannabis-in-thailand-by-dr-shiksha-gallow/
ATTACH;FMTTYPE=image/png:https://www.cannabisclinicians.org/wp-content/uploads/2023/03/SCC_IntlCmtee_30MAR23.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20230315T090000
DTEND;TZID=America/Los_Angeles:20230315T170000
DTSTAMP:20260607T072512
CREATED:20230315T132444Z
LAST-MODIFIED:20230316T105123Z
UID:10000131-1678870800-1678899600@www.cannabisclinicians.org
SUMMARY:SCC and Csequence Journal Club Presents: CBD & the Brain with Jong Rho\, MD
DESCRIPTION:This Journal Club series hosts monthly educational events where authors discuss their newly published scientific findings. Presentations will focus on a variety of articles and perspectives related to cannabis medicine\, including but not limited to clinically-relevant articles and research methodology-focused papers. \nThis month’s installment will hear Dr. Jong Rho discuss his research on how “Cannabidiol Impairs Brain Mitochondrial Metabolism and Neuronal Integrity.” \nJong M. Rho\, MD \nDr. Rho is a Professor of Neurosciences\, Pediatrics and Pharmacology at the University of California\, San Diego\, and Division Chief of Pediatric Neurology at the Rady Children’s Hospital San Diego. He received an undergraduate degree in molecular biophysics and biochemistry at Yale University\, and an M.D. from the University of Cincinnati. Dr. Rho has held prior faculty appointments at the University of Washington (Seattle) and the Seattle Children’s Hospital\, the University of California at Irvine\, the Barrow Neurological Institute (Phoenix)\, University of Arizona and Arizona State University\, and most recently\, the University of Calgary and the Alberta Children’s Hospital. Dr. Rho’s main research interests are the mechanisms underlying the anti-seizure and neuroprotective effects of metabolism-based treatments such as the ketogenic diet. His research activities have been sponsored by research grants from the U.S. National Institutes of Health\, Canadian Institutes of Health Research\, Brain Canada\, and a variety of intramural and extramural public and private sector sources. \nRegister
URL:https://www.cannabisclinicians.org/event/scc-and-csequence-journal-club-presents-cbd-the-brain-with-jong-rho-md/
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2023/03/MJC-March-15-2023-with-Dr.-Jong-Rho-2.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20230217T090000
DTEND;TZID=America/Los_Angeles:20230217T100000
DTSTAMP:20260607T072512
CREATED:20221101T150006Z
LAST-MODIFIED:20230124T164007Z
UID:10000128-1676624400-1676628000@www.cannabisclinicians.org
SUMMARY:Quarterly Meeting: Featuring Igor Grant\, MD\, FRCP(C)
DESCRIPTION:Description\nIgor Grant\, M.D.\, F.R.C.P. (C) \nDistinguished Professor\, UC San Diego\, Department of Psychiatry \nDirector\, Center for Medicinal Cannabis Research \nDr. Igor Grant is Distinguished Professor and director of the HIV Neurobehavioral Research Program and the Center for Medicinal Cannabis Research at the University of California San Diego (UCSD). Dr. Grant served as Chair of the UCSD Department of Psychiatry from 2014-2019. He is a neuropsychiatrist who graduated from the University of British Columbia School of Medicine (1966)\, and received specialty training in psychiatry at the University of Pennsylvania (1967-1971)\, and additional training in neurology at the Institute of Neurology (Queen Square) (1980-1981)\, London\, U.K. Dr. Grant’s academic interests focus on the effects of various diseases on brain and behavior\, with an emphasis on translational studies in HIV\, and drugs of abuse. He has contributed to approximately 800 scholarly publications and is principal investigator of several NIH studies. \nSince 2000\, Dr. Grant has been Director of the State of California funded Center for Medicinal Cannabis Research (CMCR). The Center was funded following passage of California Prop 215\, the “Compassionate Use Act” which envisioned providing patients under doctor supervision with access to medicinal cannabis in patients whose condition warranted it. California established the CMCR to develop a knowledge base concerning cannabis. \nHeadquartered at the University of California San Diego (UCSD)\, the Center has completed several studies on medical cannabis in relation to neuropathic pain and muscle spasticity in Multiple Sclerosis\, as well as cannabis and driving impairment. Results of the studies have been published in the scientific literature and are available at: http://www.cmcr.ucsd.edu/\, many found evidence of at least short term benefit of medicinal cannabis. \nCurrently the CMCR is conducting a number of studies on both therapeutic potentials (e.g.\, with pain\, autism\, anxiety\, metabolic syndrome\, and diabetes) and potential risks (e.g.\, automobile driving) of medicinal cannabis. Studies are beginning to explore modes of administration and specific cannabinoids (e.g.\, THC\, CBD). \nCMCR has been the source of authoritative information that is developing on medicinal cannabis and has consulted with the Legislature of the State of California\, the Office of the Lieutenant Governor of California (Blue Ribbon Commission’s Regulatory & Tax Structure Working Group)\, and contributed to the recent National Academies report\, “The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research” (2017). \nRegister
URL:https://www.cannabisclinicians.org/event/quarterly-meeting-featuring-igor-grant-md-frcpc/
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2022/11/Quarterly-Meeting-with-Igor-Grant-Feb-2023.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20230204T090000
DTEND;TZID=America/Los_Angeles:20230205T180000
DTSTAMP:20260607T072512
CREATED:20230123T155937Z
LAST-MODIFIED:20230124T163742Z
UID:10000130-1675501200-1675620000@www.cannabisclinicians.org
SUMMARY:Natural Healing Hawaii - A naturopathic lifestyle EXPO
DESCRIPTION:The natural medicine focused expo is a great opportunity for healthcare professionals to collaborate together and discuss current issues\, receive educational information\, and dialogue on key issues like the Dual Use of Cannabis Task Force panel discussion which includes Ryan’s Law. \nWhile there you can also buy some of the best medical cannabis books and informative material. Please bring strong shopping bags! Hope to see you there! \nRegister
URL:https://www.cannabisclinicians.org/event/natural-healing-hawaii-a-naturopathic-lifestyle-expo/
LOCATION:Blaisdell Exhibition Hall
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2023/01/cannabis_flyer_poster_for_wendy.001.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20230111T090000
DTEND;TZID=America/Los_Angeles:20230111T100000
DTSTAMP:20260607T072512
CREATED:20221012T162529Z
LAST-MODIFIED:20221104T143004Z
UID:10000112-1673427600-1673431200@www.cannabisclinicians.org
SUMMARY:Canna Talk: Pharmacy Edition -- Featuring Farzana Kennedy\, RPh\, BSPharm\, FACA
DESCRIPTION:Join us for “Canna Talk: Pharmacy Edition” on January 11th as we hear from our special guest Farzana Kennedy\, RPh\, BSPharm\, FACA. Dr. Kennedy will discuss her background\, how she became involved in cannabis medicine\, and answer pertinent questions related to her course module on Cannabis and Policy: Impacts on the Healthcare Environment as part of the new curriculum “Cannabis Pharmacy: The Modernization of a Novel Healthcare Industry.” \nThis educational webinar series is free for all to attend. \nEstablished cannabis pharmacists and clinicians as well as individuals new to the medical cannabis sphere are all invited to attend this conversation. This is a great platform for users who are enrolled in the Training Curriculum to ask follow-up questions that may have come up while they were taking the courses. Questions can be submitted beforehand or asked live during the webinar. Join us by registering via the link above. \nSpeakers:\nFarzana Kennedy\nAlan Ao\nBobby Vincent \nSpeaker bio:\nFarzana Kennedy\, RPh\, BSPharm\, FACA\, is the owner\, president\, and director of clinical operations of NewLeaf\, a West Virginia medical cannabis operator. She is a founding member and past president and pharmacist in charge of Dalitso LLC in Virginia where she managed all cultivation\, processing\, and dispensary functions. \nAs a founding board member and the inaugural president of the Virginia Medical Cannabis Coalition (VMCC) Farzana worked to establish and expand Virginia’s medical cannabis program by being involved in the regulatory and legislative process. She is also the chair of the Virginia Pharmacist Association (VPhA) Academy of Medical Cannabis and provides Virginia pharmacists with cannabis industry training and education. \nFarzana has over twenty-five years of compounding and clinical pharmacy experience\, most notably as the former owner and president of Alexandria Compounding Pharmacy. She is an appointee to the Northern Virginia Regional Human Rights Committee (NVRHRC) and is currently working with Virginia Department of Behavioral Health and Developmental Services as a COVID-19 clinical pharmacist consultant for the mental health and substance use disorder population. \nFarzana received her pharmacy degree from Howard University School of Pharmacy. She is a 2023 MS candidate at the University of Maryland Baltimore Graduate School Medical Cannabis Science and Therapeutics program and is a member of several professional pharmacy and cannabis organizations.
URL:https://www.cannabisclinicians.org/event/canna-talk-pharmacy-edition-featuring-farzana-kennedy-rph-bspharm-faca/
ATTACH;FMTTYPE=image/png:https://www.cannabisclinicians.org/wp-content/uploads/2022/10/MHSGcLEQ6YrmSSZGd.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20221207T090000
DTEND;TZID=America/Los_Angeles:20221207T220000
DTSTAMP:20260607T072512
CREATED:20221012T160936Z
LAST-MODIFIED:20221104T142906Z
UID:10000111-1670403600-1670450400@www.cannabisclinicians.org
SUMMARY:Canna Talk: Pharmacy Edition -- Featuring Codi Peterson\, PharmD\, MS
DESCRIPTION:Join us for “Canna Talk: Pharmacy Edition” on December 7th as we hear from our special guest Codi Peterson\, PharmD\, MS. Dr. Peterson will discuss his background\, how he became involved in cannabis medicine\, and give the insider view on the two courses he developed as part of the new curriculum “Cannabis Pharmacy: The Modernization of a Novel Healthcare Industry.” This educational webinar series is free for all to attend. \nCannabis: A Rich History Clouded in Stigma\nThe journey of cannabis through the millennia is woven between stories of agriculture\, medicine\, spirituality\, and recreation. The pathway to modern-day reformation requires an understanding of how political agendas shaped cannabis into the polarizing topic it is today. This course addresses cannabis prohibition and how the subsequent War on Drugs has disproportionately affected BIPOC communities. Course participants will learn how the stigmatization of cannabis and its consumption continues to exist today as a multifaceted issue. \nThe Future of Cannabis Medicine\nThe future of cannabis and cannabinoid-based medicine is riddled with competing interests and powerhouse industries. Prohibition has led to difficulties studying the cannabis plant on both a molecular level as well as large scale clinical trials. The endocannabinoidome is an expanded scope of what science currently knows and the questions that still need to be resolved as we move forward. The future implications of this knowledge are boundless and have the potential to significantly influence our approach to medical practices. Course participants will gain an understanding of the relationship between varying cannabinoid activity and the endocannabinoid system (ECS)\, become familiar with the expanded scope of the endocannabinoidome (eCBome)\, and much more. \nEstablished cannabis pharmacists and clinicians as well as individuals new to the medical cannabis sphere are all invited to attend this conversation. This is a great platform for users who are enrolled in the Training Curriculum to ask follow-up questions that may have come up while they were taking the courses. Questions can be submitted beforehand or asked live during the webinar. Join us by registering via the link above. \nSpeakers\nBobby Vincent\nAlan Ao\nCodi Peterson \nSpeaker bio:\nDr. Codi Peterson is a pediatric pharmacist and cannabis science expert. Leveraging a decade of clinical pharmacy experience\, Codi strives to bridge the gap between healthcare and cannabis through education and advocacy. He is PharmD graduate from Duquesne University and later graduated with an MS in Medical Cannabis Science & Therapeutics. Codi is the Chief Science Officer of The Cannigma\, a science forward media company who wants to help the world get cannabis. Dr. Peterson is also an educator for OCEMT where he teaches pharmacology to paramedics in southern California. Codi is co-founder of the Pharmacists Cannabis Coalition of California (PCCC)\, a public-benefit nonprofit dedicated to educating and elevating California pharmacists in the cannabis space. Additionally Codi is an advisor to numerous companies in the cannabis industry\, including Hembel and the Cannabis Spa Association. He believes that cannabis is medicine and patients deserve access to medicine\, which includes the right to speak with a healthcare professional.
URL:https://www.cannabisclinicians.org/event/canna-talk-pharmacy-edition-featuring-codi-peterson-pharmd-ms/
ATTACH;FMTTYPE=image/png:https://www.cannabisclinicians.org/wp-content/uploads/2022/10/Zr7wcYxpYrqDY4Ro2.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20221116T090000
DTEND;TZID=America/Los_Angeles:20221116T100000
DTSTAMP:20260607T072512
CREATED:20221012T153538Z
LAST-MODIFIED:20221103T200555Z
UID:10000110-1668589200-1668592800@www.cannabisclinicians.org
SUMMARY:Canna Talk: Pharmacy Edition -- Featuring Michael Ruggiero\, PharmD\, AAHIVP
DESCRIPTION:Join us for “Canna Talk: Pharmacy Edition” on November 16th as we explore The Cannabis Pharmacist: A Bottom-up Clinical Approach with Michael Ruggiero\, PharmD\, AAHIVP. Dr. Ruggerio will discuss his background\, how he became involved in cannabis medicine\, and provide a glimpse into the material covered in his course. This course addresses the primary differences between the medical cannabis industry and traditional pharmaceuticals\, teaches participants how to confidently develop tailor-made dosing protocols for patients\, and how to comprehend the nuances of various dosage forms and ROAs for cannabinoid-based products\, along with much more. If you are interested in taking the course beforehand so that you can ask your questions live\, you can purchase the course here. \nThis educational webinar series is free for all to attend. \nEstablished cannabis pharmacists and clinicians as well as individuals new to the medical cannabis sphere are all invited to attend this conversation. This is a great platform for users who are enrolled in the Training Curriculum to ask follow-up questions that may have come up while they were taking the courses. Questions can be submitted beforehand or asked live during the webinar. Join us by registering via the link above. \nSpeakers:\nAlan Ao\nBobby Vincent\nMichael Ruggiero \nSpeaker Bio: \nDr. Michael Ruggiero is the Regional Pharmacy Manager for Beyond / Hello in Pennsylvania. Prior to entering the Cannabis Industry he worked as a community pharmacist with certifications in medication therapy management\, HIV\, and cannabis. Since beginning to work in the industry he has given educational presentations on cannabis to healthcare and non-healthcare professionals alike\, spoke on a podcast for Cannigma\, provided Veteran driven education\, created knowledge assessments for his team\, developed oral product formulation dosing charts for the products at his dispensary\, and currently is Vice President of International Society of Cannabis Pharmacists. In addition he teaches HIV pharmacotherapeutics to Physician Assistant students at Thomas Jefferson University.
URL:https://www.cannabisclinicians.org/event/canna-talk-pharmacy-edition-featuring-michael-ruggiero-pharmd-aahivp/
ATTACH;FMTTYPE=image/png:https://www.cannabisclinicians.org/wp-content/uploads/2022/10/DZZJzu4YHqDsR2XWq.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20221012T213000
DTEND;TZID=America/Los_Angeles:20221012T223000
DTSTAMP:20260607T072512
CREATED:20220921T170340Z
LAST-MODIFIED:20220922T123824Z
UID:10000109-1665610200-1665613800@www.cannabisclinicians.org
SUMMARY:Canna Talk: Pharmacy Edition -- Featuring Curriculum Co-Directors
DESCRIPTION:Don’t miss the kickoff event “Canna Talk: Pharmacy Edition” on October 12th as we explore the course material that is covered in the new curriculum: Cannabis Pharmacy: The Modernization of a Novel Healthcare Industry. \nThis educational webinar series is free for all to attend. The curriculum co-directors Alan Ao\, PharmD and Bobby Vincent\, III\, PharmD\, RPh will share a brief overview of what course participants can expect to learn after completing this curriculum and will also delve deeper into the specific topics that Dr. Alan Ao covers in his module The Cannabis Pharmacist: A Bottom-up Clinical Approach. Learn more in their bios below. \nEstablished cannabis pharmacists and clinicians as well as individuals new to the medical cannabis sphere are all invited to attend this conversation. This is a great platform for users who are enrolled in the Training Curriculum to ask follow-up questions that may have come up while they were taking the courses. Questions can be submitted beforehand or asked live during the webinar. Join us by registering via the link above. \nSpeakers:\nAlan Ao\, PharmD\, Bobby Vincent \nAlan Ao\, PharmD\nDr. Alan Ao is a registered pharmacist and lifelong NJ native. With over 20 years of retail experience\, the majority of his professional career has been spent working alongside patients in independent retail settings specializing in patient care counseling\, prescription drug compounding\, and alternative medicine. Dr. Ao served as Vice President/Clinical Pharmacist in one of New Jersey’s first vertically integrated alternative treatment centers for 2.5 years before launching his own consulting firm. He’s the Founder and President of Plants and Prescriptions – a consulting firm developing an industry where cannabis and modern-day healthcare collide through education and advocacy. He currently serves as an advisory board member for the Association of Cannabis Health Equity and Medicine and pharmacy course director for the Society of Cannabis Clinicians. Dr. Ao is also involved as a course instructor for dispensary operations for both NJ Cannabis Certified and the Minority Cannabis Academy. \nBobby Vincent\, III\, PharmD\, RPh\nBobby Vincent\, III\, PharmD\, RPh is a Clinical Cannabinoid Pharmacotherapist born and raised in Richmond\, Virginia. Dr. Vincent is driven by a passion to bridge the medical cannabis industry with communities in need. Dr. Vincent currently serves the northern Virginia and Washington\, D.C. metropolitan area as a pharmacist and medical consult– providing care for hundreds of cannabis patients. Dr. Vincent is the founder of Cannabis Health Alliances\, LLC.\, building partnerships to advance therapy\, policy and patient accessibility. He also serves as the Communications Chair for the Virginia Pharmacists Association Academy of Medical Cannabis and a member of the organization’s Task Force for Racial Diversity\, Equity\, and Inclusion. \nDr. Vincent is a graduate of Hampton University where he obtained a Doctor of Pharmacy degree. He recently earned his Masters of Cannabis Science and Therapeutics Degree at the University of Maryland\, Baltimore – the first degree of its kind available in the United States. He has experienced a host of unique learning opportunities\, including time abroad in Thailand\, United Arab Emirates\, and the Philippines as a medical volunteer. Dr. Vincent also spent time with the National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA) Office of Science Policy and Communications as a pharmacy intern. \nTo join as a listener\, enter code 856348569 \nRegister to Attend
URL:https://www.cannabisclinicians.org/event/canna-talk-pharmacy-edition-featuring-curriculum-co-directors/
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2022/09/SCC-CannaTalk-Pharmacy-Edition-Oct-12-22-post.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20221007T090000
DTEND;TZID=America/Los_Angeles:20221007T100000
DTSTAMP:20260607T072512
CREATED:20220804T143249Z
LAST-MODIFIED:20220804T174921Z
UID:10000108-1665133200-1665136800@www.cannabisclinicians.org
SUMMARY:Monthly Journal Club – Dr. Thomas Marcotte\, The Complex Relationship Between Cannabis and Driving
DESCRIPTION:Speaker:\nThomas Marcotte\, PhD \nArticle: \nDriving Performance and Cannabis Users’ Perception of Safety: A Randomized Clinical Trial \nMeet Dr. Thomas Marcotte: \nDr. Thomas Marcotte is Professor of Psychiatry at the University of California\, San Diego\, and Co-Director of the Center for Medicinal Cannabis Research\, which has conducted clinical trials of cannabis for over 20 years and has an active\, ongoing portfolio exploring the effects of cannabinoids (plant-based\, synthetic) in various medical/psychiatric conditions. He is the principal investigator on studies addressing the effects that cannabis has on driving performance\, including in combination with alcohol\, as well as methods for detecting cannabis-related driving impairment. He is currently a principal investigator on a study examining cannabis for the treatment of sports-related injuries in elite athletes\, and previously was the principal investigator on an NIH-funded take-home study of cannabis for the treatment of pain\, and a co-investigator on cannabis studies addressing pain\, as well spasticity in multiple sclerosis. Dr. Marcotte has served on the editorial boards of Neuropsychology and the Journal of the International Neuropsychological Society\, was co-chair of the Research\, Data and Technology subcommittee of the State of California Impaired Driving Task Force\, and a member on the California Office on Traffic Safety Impaired Driving Blueprint Roundtable. He is co-editor of the book Neuropsychology of Everyday Functioning\, 2nd Edition (Marcotte\, Schmitter-Edgecombe & Grant) \nRegister to Attend
URL:https://www.cannabisclinicians.org/event/csequence-scc-journal-club-thomas-marcotte-driving-performance-and-cannabis-users-perception-of-safety-a-randomized-clinical-trial/
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2022/08/MJC-Oct-7-2022.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220907T090000
DTEND;TZID=America/Los_Angeles:20220907T100000
DTSTAMP:20260607T072512
CREATED:20220804T141839Z
LAST-MODIFIED:20220805T100514Z
UID:10000107-1662541200-1662544800@www.cannabisclinicians.org
SUMMARY:Monthly Journal Club - Dr. Ran Abuhasira\, Cannabis is associated with Blood Pressure Reduction in Older Adults
DESCRIPTION:September 7\, 2022 \nSpeaker: \nRan Abuhasira\, MD PhD\, \nArticle: \nCannabis is Associated with Blood Pressure Reduction in Older Adults: A 24-hour ambulatory blood pressure monitoring study \nMeet Dr. Ran Abuhasira \nDepartment of Internal Medicine B\, Rabin Medical Center\, Beilinson Campus. \nDr. Abuhasira completed his PhD at the Cannabis Clinical Research Institute (CCRI) under the supervision of Prof. Victor Novack. The CCRI is part of the Clinical Research Center at Soroka University Medical Center in Beer-Sheva\, Israel. His study focused on assessing the safety and efficacy of medical cannabis in the elderly population. His work was published in a number of papers and presented in scientific conferences worldwide. \nRegister to Attend
URL:https://www.cannabisclinicians.org/event/monthly-journal-club-dr-ran-abuhasira-cannabis-is-associated-with-blood-pressure-reduction-in-older-adults/
LOCATION:Society of Cannabis Clinicians
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2022/08/MJC-Sept-7-2022.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220902T080000
DTEND;TZID=America/Los_Angeles:20220903T170000
DTSTAMP:20260607T072512
CREATED:20220804T120908Z
LAST-MODIFIED:20220805T101725Z
UID:10000106-1662105600-1662224400@www.cannabisclinicians.org
SUMMARY:First International Congress on Medical Use of Cannabis and Entheogens
DESCRIPTION:Tuesday\, September 2\, 2022 – Wednesday\, September 3\, 2022 \nEvent Description \nAn academic conference with a clear objective\, to bring together cannabis and entheogen experts to present scientific evidence and experience from their role in science and society; following the principles of ethics\, empathy and with the human vision of medicine\, for Peru and the world.
URL:https://www.cannabisclinicians.org/event/first-international-congress-on-medical-use-of-cannabis-and-entheogens/
LOCATION:Lima\, Peru
ATTACH;FMTTYPE=image/png:https://www.cannabisclinicians.org/wp-content/uploads/2022/08/FLYER_CONGRESS_INGLES.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220701T090000
DTEND;TZID=America/Los_Angeles:20220701T103000
DTSTAMP:20260607T072512
CREATED:20220525T052110Z
LAST-MODIFIED:20220628T043637Z
UID:10000105-1656666000-1656671400@www.cannabisclinicians.org
SUMMARY:CSequence & The Society of Cannabis Clinicians Presents Journal Club: Cannabis vs. Opioids For Back Pain- Two New Studies
DESCRIPTION:The Society of Cannabis Clinicians Journal Club Featuring Dr. Dustin Sulak \nFriday\, July 1\, 2022 \nEvent Description\n\nJoin us for the upcoming SCC Journal Club featuring Dr. Dustin Sulak as he shares his presentation on “Cannabis vs. Opioids For Back Pain: Two New Studies!” \nIf you are not an SCC member\, please click “Sign Up” at the top of the page in order to Register. The event is free for SCC members\, and $20 for non-members. To learn more about the Society of Cannabis Clinicians or join as a member\, click here. \nMeet Dr. Dustin Sulak: \nDr. Dustin Sulak \nDustin Sulak\, D.O. is an osteopathic physician\, licensed in Maine as a general practitioner. He is an expert in integrative medicine\, the intelligent combination of conventional and alternative approaches to healthcare. He has long been fascinated by mind-body medicine\, spirituality in healthcare\, and natural approaches to promoting health and healing. He is an expert in cranial and biodynamic osteopathy\, a clinical hypnotherapist\, Reiki sensei\, practitioner of chi kung and yoga\, and has studied with numerous conventional and alternative healers and physicians. \nDr. Sulak’s clinical practice focuses on treating refractory conditions in adults and children.  He received undergraduate degrees in nutrition science and biology from Indiana University\, a doctorate of osteopathy from the Arizona College of Osteopathic Medicine\, and completed an osteopathic internship at Maine-Dartmouth Family Medicine Residency.  Dr. Sulak is the founder of Integr8 Health and Healer.com\, a medical cannabis education resource.  He is a passionate teacher of clinicians\, patients and industry professionals\, and sits on the board of directors of two nonprofits focused on cannabis education\, The Society of Cannabis Clinicians and Patients Out of Time. \n\nRegister to Attend
URL:https://www.cannabisclinicians.org/event/csequence-the-society-of-cannabis-clinicians-presents-journal-club-cannabis-vs-opioids-for-back-pain-two-new-studies/
LOCATION:Society of Cannabis Clinicians
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2022/05/2.jpeg
ORGANIZER;CN="SCC & CSequence":MAILTO:info@cannabisclincians.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220624T090000
DTEND;TZID=America/Los_Angeles:20220624T103000
DTSTAMP:20260607T072512
CREATED:20220503T173820Z
LAST-MODIFIED:20220503T173820Z
UID:10000104-1656061200-1656066600@www.cannabisclinicians.org
SUMMARY:The SCC Quarterly Meeting: Acidic Cannabinoids: Inactive Precursors or Powerful Therapeutics
DESCRIPTION:The Society of Cannabis Clinicians Quarterly Meeting Featuring Dr. Dustin Sulak \nFriday\, June 24\, 2022 \nEvent Description\n\nJoin us for the upcoming SCC Quarterly Meeting featuring Dr. Dustin Sulak as he shares his presentation on “Acidic Cannabinoids: Inactive Precursors or Powerful Therapeutics!” \nIf you are not an SCC member\, please click “Sign Up” at the top of the page in order to Register. The event is free for SCC member\, and $20 for non-members. To learn more about the Society of Cannabis Clinicians or join as a member\, click here. \nMeet Dr. Dustin Sulak: \nDr. Dustin Sulak \nDustin Sulak\, D.O. is an osteopathic physician\, licensed in Maine as a general practitioner. He is an expert in integrative medicine\, the intelligent combination of conventional and alternative approaches to healthcare. He has long been fascinated by mind-body medicine\, spirituality in healthcare\, and natural approaches to promoting health and healing. He is an expert in cranial and biodynamic osteopathy\, a clinical hypnotherapist\, Reiki sensei\, practitioner of chi kung and yoga\, and has studied with numerous conventional and alternative healers and physicians. \nDr. Sulak’s clinical practice focuses on treating refractory conditions in adults and children.  He received undergraduate degrees in nutrition science and biology from Indiana University\, a doctorate of osteopathy from the Arizona College of Osteopathic Medicine\, and completed an osteopathic internship at Maine-Dartmouth Family Medicine Residency.  Dr. Sulak is the founder of Integr8 Health and Healer.com\, a medical cannabis education resource.  He is a passionate teacher of clinicians\, patients and industry professionals\, and sits on the board of directors of two nonprofits focused on cannabis education\, The Society of Cannabis Clinicians and Patients Out of Time. \n\nRegister to Attend
URL:https://www.cannabisclinicians.org/event/the-scc-quarterly-meeting-acidic-cannabinoids-inactive-precursors-or-powerful-therapeutics/
LOCATION:Society of Cannabis Clinicians
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2022/05/unnamed.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20220520T084500
DTEND;TZID=Australia/Sydney:20220522T150000
DTSTAMP:20260607T072512
CREATED:20210423T112041Z
LAST-MODIFIED:20210906T124420Z
UID:10000079-1653036300-1653231600@www.cannabisclinicians.org
SUMMARY:Australian Medicinal Cannabis Symposium
DESCRIPTION:The United in Compassion Australian Medicinal Cannabis Symposium began as a patient led movement that changed the law and inspired a new industry for the benefit of Australian patients. Their focus remains on patients and helping them with better access by providing better education of the health workforce and promoting development of a viable\, professional and patient focused industry. \nPatients\, clinicians\, researchers and industry come together to examine exciting developments and to hear from renowned experts from home and from around the globe. \n  \nMORE INFO >>
URL:https://www.cannabisclinicians.org/event/united-in-compassion-australian-medicinal-cannabis-symposium/
ATTACH;FMTTYPE=image/png:https://www.cannabisclinicians.org/wp-content/uploads/2021/04/australia-cannabis-conference-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220506T090000
DTEND;TZID=America/Los_Angeles:20220506T093000
DTSTAMP:20260607T072512
CREATED:20220421T141840Z
LAST-MODIFIED:20220421T141840Z
UID:10000103-1651827600-1651829400@www.cannabisclinicians.org
SUMMARY:SCC & CSequence Presents Journal Club: "Cannabis Consumption Used by Cancer Patients during Immunotherapy Correlates with Poor Clinical Outcome!"
DESCRIPTION:Friday\, May 6\, 2022 at 9am PDT / 12pm EDT \nResearch Presentation: SCC & CSequence Presents Journal Club: “Cannabis Consumption Used by Cancer Patients during Immunotherapy Correlates with Poor Clinical Outcome!” \nSpeaker: Dr. Mihkail Kogan \nModerator: Zach Moore\, PhD \nEvent registration link: \nhttps://cannabisclinicians.tradewing.com/event/YsyEfdp5favrgo2r7 \nJoin us for an educational discussion with Mikhail Kogan\, MD as he highlights his recent research article “Cannabis Consumption Used by Cancer Patients during Immunotherapy Correlates with Poor Clinical Outcome.” \nLearn More About Mikhail Kogan: \n \nDr. Mikhail Kogan\, MD is a Medical Director\, GW Center for Integrative Medicine\, and the Assistant Professor\, George Washington University School of Medicine and Health Sciences. \nHe is an Integrative Medicine Fellowship Director\, Primary Care Internal Medicine\, Integrative Geriatrics\, Functional Medicine\, Integrative Palliative Care Physician. \nHe is also the founder and Executive Director of ex-officio\, of AIM Health Institute\, a 501 (c) (3) non-profit  organization \nDr. Kogan is a founding Board Member of the American Board of Integrative Medicine\, and a Board Member of the Art of Healing Foundation. \nDr Kogan is a leader in the newly-established field of Integrative Geriatrics. He is the chief editor of the first definitive textbook of the field entitled “Integrative Geriatric Medicine ”\, published by Oxford University Press as part of Andrew Weil Integrative Medicine Library series and is frequent speaker at a variety of international conferences on the topics of Integrative Medicine and Geriatrics\, healthy aging\, and geriatrics\, as well as neurodegenerative diseases\, and use of medical cannabis. Additionally\, he has published in both Integrative and Geriatric topics in leading US-based journals. \nDr. Kogan currently serves as medical director of the GW Center for Integrative Medicine and associate director of the Geriatrics Fellowship Program. He is the founder and director othe George Washington University Integrative Geriatrics Fellowship Track and the director of the Integrative Medicine Track program at the George Washington University School of Medicine\, as well as serving as part-time faculty member of the George Washington Institute for Spirituality and Health\, and the GW Center for Aging\, Health and Humanities. \nIn addition to his academic roles at George Washington University Dr. Kogan serves on a number of national boards and organizations including: the American Board of Integrative Medicine within the American Board of Physician Subspecialists (ABPS)\, ProCure Art\, PlantMed\, and others. Dr Kogan is also the founder and the chair of the board of AIM Health Institute\, a 501(c)(3) non-profit organization in the Washington\, D.C. metropolitan area that provides integrative medicine services to low-income and terminally ill patients regardless of their ability to pay. \nFor Dr. Mikhail Kogan\, the practice of medicine\, much like the rest of his life\, has been a journey spanning many miles and many cultures\, with valuable new learning and different perspectives accruing from each stage along the way. Those many experiences – here and abroad\, in the classroom and the clinic\, professionally and personally – have given Dr. Kogan the skills\, \, openness\, and inquisitiveness that set him apart\, and distinguish him as a committed and caring practitioner within integrative medicine. \nBorn in Moscow\, in the former Soviet Union\, Dr. Kogan emigrated with his family in his teens\, first to Israel\,and then to the United States\, where he obtained his medical degree from the Drexel University College of Medicine in Philadelphia\, Pennsylvania. He followed a Primary Care and Social Medicine Track residency in Internal Medicine at Montefiore Medical Center in New York City\, and a fellowship in Geriatric Medicine at the George Washington University Medical Center in Washington\, D.C.\, which led to a position as an assistant professor of medicine in the Division of Geriatrics and Palliative Care. \nIn addition to his training in conventional Western medicine\, Dr. Kogan has actively pursued a number of other healing arts and practices that have shaped his understanding of and approach to patient care. He is a graduate of a two-year training course in craniosacral therapy–a subtle osteopathic modality that has a wide range of effectiveness for different conditions such as headaches\, back pains\, and fatigue. He has also completed a four-year program at the Suluk Academy\, a teaching center based on the principles and traditions of Sufism\, where he learned how to incorporate meditation\, mindfulness\, and different spiritual practices into his daily life and his work with the patients. Among his many other areas of study are courses in Nutrition\, therapeutic use of vitamins\, Functional Medicine\, botanicals\, and other alternative modalities. \nWeaving those tools into the fabric of his medical practice has enabled Dr. Kogan to provide innovative and effective treatments to his patients with minimal use of invasive procedures or heavy reliance on medications and to understand the importance of self-exploration\, awareness and positive lifestyle changes as essential milestones on his patients’ journeys towards better health. Dr. Kogan is dedicated to helping patients with Alzheimer’s disease identify and correct underlying metabolic drivers work\, which is primarily based on Dr. Dale Bredesen’s research and newly created ReCode protocol. \nDr. Kogan practices Geriatric and Integrative Medicine in a variety of settings: at the George Washington Hospital\, at the GW Center for Integrative medicine\, as well as serving patients in home visits. \nRegister to Attend
URL:https://www.cannabisclinicians.org/event/scc-csequence-presents-journal-club-cannabis-consumption-used-by-cancer-patients-during-immunotherapy-correlates-with-poor-clinical-outcome/
LOCATION:Society of Cannabis Clinicians
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2022/04/Monthly-Journal-Club-May-with-Mikahil-Kogan.jpg
ORGANIZER;CN="SCC & CSequence":MAILTO:info@cannabisclincians.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220415T110000
DTEND;TZID=America/Los_Angeles:20220415T123000
DTSTAMP:20260607T072512
CREATED:20220411T025604Z
LAST-MODIFIED:20220413T163300Z
UID:10000102-1650020400-1650025800@www.cannabisclinicians.org
SUMMARY:SCC & CSequence Journal Club Presents: "State Medical Cannabis Programs: What Physicians Should Know And Consider" Hosted By Richard Cheng\, JD\, CHC
DESCRIPTION:Friday\, April 15\, 2022 at 11am PDT / 2pm EDT\n\nResearch Presentation: “State Medical Cannabis Programs: What Physicians Should Know And Consider”\n\nSpeaker: Richard Cheng\, JD\, CHC \nModerator: Zach Moore\, PhD\n\nEvent registration link: https://cannabisclinicians.tradewing.com/event/Q5HfwtB9iCxhaMCed\nJoin us for a robust discussion with Richard Cheng\, JD\, CHC\, as we learn more about “State Cannabis Laws.” \n\nLearn More About Richard Cheng: \nRichard Cheng\, JD\, CHC \nRichard Cheng is a healthcare and cannabis regulatory and corporate attorney\, specializing in representing healthcare providers and cannabis businesses. He is also a healthcare professional holding a degree in Occupational Therapy (BSOT). \n\nRegister to Attend
URL:https://www.cannabisclinicians.org/event/scc-csequence-journal-club-presents-state-medical-cannabis-programs-what-physicians-should-know-and-consider-hosted-by-richard-cheng-jd-chc/
LOCATION:Society of Cannabis Clinicians
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2022/04/Monthly-Journal-Club-with-Richard-Cheng-1.jpg
ORGANIZER;CN="SCC & CSequence":MAILTO:info@cannabisclincians.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220408T090000
DTEND;TZID=America/Los_Angeles:20220408T090000
DTSTAMP:20260607T072512
CREATED:20220301T044704Z
LAST-MODIFIED:20220315T141155Z
UID:10000101-1649408400-1649408400@www.cannabisclinicians.org
SUMMARY:SCC Quarterly Meeting: Dr. Lauren Streicher\, "The Use of Cannabinoids in Menopause"
DESCRIPTION:Event Description\n\nJoin us for the upcoming SCC Quarterly Meeting featuring Dr. Lauren Streicher as she shares her presentation on “The Use of Cannabinoids in Menopause.” \nIf you are not an SCC member\, please click “Sign Up” at the top of the page in order to Register. The event is free for SCC member\, and $20 for non-members. To learn more about the Society of Cannabis Clinicians or join as a member\, click here. \nLearn More About This Event:  \nThere are over 60 million menopause women in the United States\, and over 80% of those women experience debilitating  and life shortening symptoms such as hot flashes and insomnia. Only 7% get a prescription to relieve those symptoms since there is a persistent (and false) perception that estrogen is dangerous. Many post menopause women are turning to cannabis. Dr. Lauren Streicher\, a clinical professor of Obstetrics and Gynecology at the Feinberg School of Medicine\, Northwestern University\, and the Medical Director of the Northwestern Medicine Program for Menopause will discuss the potential role of cannabinoids in menopausal women. \nMeet Dr. Lauren Streicher: \n \nLauren Streicher\, MD is a clinical professor of obstetrics and gynecology at Northwestern University’s Feinberg School of Medicine\, and the medical director of the Northwestern Medicine Center for Sexual Medicine and Menopause. She is a certified menopause practitioner of the North American Menopause Society\, a member of the Sexual Medicine Society of North America\, Inc.\, The International Society for the Study of Women’s Sexual Health\, and The Scientific Network on Female Sexual Health and Cancer. In addition to authoring multiple scientific publications\, she has written multiple consumer books. Her most recent releases are Slip Sliding Away: Turning Back the Clock on Your Vagina and Hot Flash Hell: A Gynecologist’s Guide to Turning Down the Heat. \nDr. Streicher is the medical correspondent for Chicago’s top-rated news program\, the WGN Morning News\, and has appeared multiple times on The Today Show\, Good Morning America\, The Oprah Winfrey Show\, CNN\, NPR\, Dr. Radio\, Nightline\, Fox and Friends\, The Steve Harvey Show\, CBS This Morning\, ABC News Now\, NBC Nightly News\, 20/20\, and World News Tonight. She lives in Chicago with her writer-producer husband\, Jason Brett\, and their dog\, KJ. \n\nRegister to Attend
URL:https://www.cannabisclinicians.org/event/scc-quarterly-meeting-dr-lauren-streicher-the-use-of-cannabinoids-in-menopause/
LOCATION:Society of Cannabis Clinicians
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2022/02/Quarterly-meeting-with-Dr.-Streicher-IG-FB.jpg
ORGANIZER;CN="Society of Cannabis Clinicians":MAILTO:info@cannabisclinicians.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220314
DTEND;VALUE=DATE:20220316
DTSTAMP:20260607T072512
CREATED:20220114T022112Z
LAST-MODIFIED:20220114T030711Z
UID:10000099-1647216000-1647388799@www.cannabisclinicians.org
SUMMARY:CannX-Tel Aviv
DESCRIPTION:CannX Tel Aviv is the meeting point for global leaders in all areas of Medical Cannabis. First-hand knowledge and networks are essential in understanding the way forward within the complex ecosystem of medical cannabis. CannX 2022 will provide a unique opportunity to gather once again in-person in the beautiful city of Tel Aviv. Join the world’s most influential scientists\, clinicians\, entrepreneurs\, investors\, policymakers\, and thought leaders for the ultimate opportunity to make an impact in the field. We haven’t had the chance to meet since 2020 due to the restrictions imposed by the Covid-19 pandemic and look forward to seeing you in person in Israel’s most cosmopolitan and vibrant city – Tel Aviv.
URL:https://www.cannabisclinicians.org/event/cannx-telaviv/
LOCATION:Tel Aviv\, Israel
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2022/01/CannX19-434-300x200-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220304T090000
DTEND;TZID=America/Los_Angeles:20220304T090000
DTSTAMP:20260607T072512
CREATED:20220208T221302Z
LAST-MODIFIED:20220301T211456Z
UID:10000100-1646384400-1646384400@www.cannabisclinicians.org
SUMMARY:Monthly Journal Club: Bonni Goldstein\, MD & Itzhak Kurek\, PhD - Cannabis-Responsive Biomarkers & Autism Spectrum Disorder
DESCRIPTION:March 4\, 2022 at 9am PST / 12pm EST\n\nArticle: Cannabis-Responsive Biomarkers: A Pharmacometabolomics-Based Application to Evaluate the Impact of Medical Cannabis Treatment on Children with Autism Spectrum Disorder.\n\nSpeakers: Bonni Goldstein\, MD & Itzhak Kurek\, PhD \nModerator: Zach Moore\, PhD\n\nEvent registration link: https://cannabisclinicians.tradewing.com/event/Q5HfwtB9iCxhaMCed\nJoin us for a robust discussion with Bonni Goldstein\, MD & Itzhak Kurek\, PhD moderated by Zach Moore\, PhD as we discover their newest publication\, “Cannabis-Responsive Biomarkers: A Pharmacometabolomics-Based Application to Evaluate the Impact of Medical Cannabis Treatment on Children with Autism Spectrum Disorder.” \nAutism spectrum disorder (ASD) is a group of neurodevelopmental conditions that impact behavior\, communication\, social interaction\, and learning abilities. Treatment of ASD with medical cannabis (MC) shows promising results in reducing the severity of certain behavioral aspects. The goals of this observational study are to demonstrate the potential of metabolic biomarkers to (1) objectively determine the impact on metabolites of MC treatment and (2) suggest the metabolic pathways of children with ASD\, who respond to MC treatment. \n\nLearn More About Dr. Bonni Goldstein: \nDr. Bonni Goldstein \nBonni Goldstein\, MD is the Medical Director of Canna-Centers Wellness & Education\, a California-based medical practice devoted to educating patients about the use of cannabis for serious and chronic medical conditions.  She completed her internship and residency at Children’s Hospital Los Angeles\, where she also served as chief resident.  After years of working in the specialty of Pediatric Emergency medicine\, she developed an interest in the science of medical cannabis after witnessing its beneficial effects in an ill friend.  Over the last 13 years she has evaluated thousands of patients for use of medical cannabis and is recognized as an expert in the clinical application of cannabis therapeutics.  She has a special interest in treating children with intractable epilepsy\, autism\, cancer and other conditions. Her latest book\, “Cannabis is Medicine: How Medical Cannabis and CBD are Healing Everything from Anxiety to Chronic Pain” was published in September 2020 by Little\, Brown Spark. Dr. Goldstein recently co-authored a peer-reviewed article researching the use of Cannabis-Responsive biomarkers to document cannabis treatment efficacy\, guide clinical decision-making and improve outcomes. \n\nLearn More About Itzhak Kurek\, PhD: \nItzhak Kurek\, PhD \nItzhak Kurek\, PhD is the co-founder and CEO of Cannformatics\, Inc. a San Francisco-based biotechnology startup developing saliva-based Cannabis-Responsive™ biomarkers as a universal tool for the objective measurement of the physiological impact of any cannabinoid-based treatment. He has executive and research management experience in the Ag-Biotech\, Nutritional Supplements and Biobased Products businesses. Previously he held positions at Solix Algredients\, Kiverdi\, Pioneer Hi-Bred (DuPont) and Maxygen. He has published over 70 peer-reviewed scientific papers and patents. Dr. Kurek received his Ph.D. in Plant Sciences from Tel Aviv University and completed his postdoctoral research at the University of California\, Davis. Dr. Kurek has also conducted research at the Technical University of Munich\, John Innes Center Norwich\, C.N.R.S Bordeaux and the Lawrence Berkeley National Laboratories. \n  \nREGISTER TO ATTEND
URL:https://www.cannabisclinicians.org/event/monthly-journal-club-bonni-goldstein-md-itzhak-kurek-phd-cannabis-responsive-biomarkers-autism-spectrum-disorder/
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2022/02/CannaTalk-with-Dr.-Goldstein-Kurek-IGFB.jpg
ORGANIZER;CN="Society of Cannabis Clinicians":MAILTO:info@cannabisclinicians.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220127
DTEND;VALUE=DATE:20220130
DTSTAMP:20260607T072512
CREATED:20220112T184549Z
LAST-MODIFIED:20220112T192920Z
UID:10000098-1643241600-1643500799@www.cannabisclinicians.org
SUMMARY:Cannabis Science & Industry Congress
DESCRIPTION:January 27-29\, 2022 | San Jose\, Costa Rica \nThe Cannabis Congress has partnered with the Society of Cannabis Clinicians to develop the Medical Track of the event featuring clinicians and researchers presenting the latest research and clinical findings on the therapeutic applications of cannabis. Doctors from Latin America\, the United States\, the EU\, and Canada will be addressing an array of the most sought-after clinical topics from pain\, sleep\, epilepsy\, mental health and more\, to clinician activism\, historical perspectives and indigenous knowledge of cannabis medicine. \n  \nMORE INFO >> \n  \n 
URL:https://www.cannabisclinicians.org/event/cannabis-science-industry-congress/
LOCATION:Parque Viva Main Gate\, Alajuela\, Costa Rica
ATTACH;FMTTYPE=image/png:https://www.cannabisclinicians.org/wp-content/uploads/2021/12/cannabis-for-tic-disorders.png
ORGANIZER;CN="Cannabis Science and Industry Congress":MAILTO:info@thecannabiscongress.net
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220113T090000
DTEND;TZID=America/Los_Angeles:20220113T100000
DTSTAMP:20260607T072512
CREATED:20211207T103115Z
LAST-MODIFIED:20220112T181310Z
UID:10000097-1642064400-1642068000@www.cannabisclinicians.org
SUMMARY:Monthly Journal Club: Dr. Josh Kaplan on CBD Exposure and Behavioral Changes in Mice
DESCRIPTION:9-10am PDT / 11am-1pm Colombia / 12-1pm EST / 5-6pm UK \nThe SCC Journal Club meets monthly the first Friday of every month. Presentations will focus on a variety of articles and perspectives related to cannabis medicine\, including but not limited to clinically-relevant articles and research methodology-focused papers. This month’s installment will hear Dr. Josh Kaplan discuss a paper on adolescent CBD exposure in mice not having substantive negative impacts on a range of behaviors in adulthood. It may also improve the rate of learning under certain conditions. \nPresenter:\nDr. Josh Kaplan \nArticle to be Discussed:\n\nCannabidiol Exposure During the Mouse Adolescent Period Is Without Harmful Behavioral Effects on Locomotor Activity\, Anxiety\, and Spatial Memory\n\nFREE for SCC members. $10 for non members.  \nWant to sign up to present an article? Contact us here. \nLearn more about SCC membership options. \n  \nREGISTRATION >> \n  \nDr. Josh Kaplan Josh Kaplan earned his Ph.D. in Behavioral Neuroscience in 2015 from Oregon Health & Science University and then joined the University of Washington for two postdoctoral fellowships where he trained in cannabinoid pharmacology. His work has contributed towards our understanding of the therapeutic potential of phytocannabinoids and the body’s endocannabinoid system. Dr. Kaplan’s research was instrumental in demonstrating the effectiveness of cannabidiol (CBD) as a monotherapy in treating medically-refractory seizures and improving autism-like social interaction deficits using pre-clinical genetic models of disease. Further\, he utilized his expertise in electrophysiology and pharmacological techniques to demonstrate a significant non-endocannabinoid mechanism-of-action by which CBD achieves its therapeutic relevance. His later studies focused on the therapeutic utility of enhancing endocannabinoid function and the relevant interactions with other inhibitory systems in the brain. \nDr. Kaplan is currently an Assistant Professor of Behavioral Neuroscience at Western Washington University in Bellingham\, WA\, where he trains undergraduate and graduate students in his cannabis research lab. By utilizing animal behavioral\, molecular\, pharmacological\, and electrophysiological techniques\, the Kaplan lab is working to identify ways of improving the plant’s therapeutic benefits and safety across a range of conditions. Their aim is to identify optimized cannabinoid and terpene compositions that extend the therapeutic dosing range while bolstering efficacy and limiting adverse effects. \nBeyond the lab\, Dr. Kaplan is a devoted mentor\, educator\, and science communicator. He has contributed numerous articles to peer reviewed journals\, book chapters\, as well as written for websites and magazines including High Times\, Cannabis and Tech Today\, and Leafly. He’s also spoken internationally on cannabis science for all types of audience and consulted for documentaries and popular science books. He was included in High Times’ 100 Most Influential People in Cannabis in 2018.
URL:https://www.cannabisclinicians.org/event/monthly-journal-club-dr-josh-kaplan/
LOCATION:Zoom
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2021/12/JournalClub-with-Dr.-Kaplan-Cseq-IgFb-.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20211216T090000
DTEND;TZID=America/Los_Angeles:20211216T103000
DTSTAMP:20260607T072512
CREATED:20211012T141021Z
LAST-MODIFIED:20211213T094652Z
UID:10000095-1639645200-1639650600@www.cannabisclinicians.org
SUMMARY:Cannabis & Psychedelics Webinar
DESCRIPTION:Join us for the inaugural Cannabis & Psychedelics Webinar put on by the Society of Cannabis Clinicians is co-hosting with the Psychedelic Medicine Association. \nThe event will focus on highlighting the psychedelic effects of cannabis and the therapeutic approaches of how cannabis can be used in conjunction with psychedelics (for example\, in between psychedelic-assisted therapy sessions to prolong the therapeutic benefits or within sessions to enhance effects\, etc.). The webinar will also focus on research on how psychedelics engage with the endocannabinoid system. The featured speakers will highlight their work in the field of psychedelic medicine to provide information on how clinicians can get training to utilize entheogens in their clinical practice. \nSpeakers & Topics: \n\nDustin Sulak\, DO: Beyond the Crutch and the Tonic: Cannabis as a Teacher\nSaj Razvi\, LPC: Cannabis & the Autonomic Nervous System: A Preferential Pathway for Psychedelic Therapy\nRebecca Kronman\, LCSW: Facing stigmas of medical cannabis and psychedelic-assisted therapies for clinicians and patients\nMark Braunstein\, DO\, ABPN: Psychiatric and medical considerations\, cannabis dosing as part of ketamine protocols\nMatthew Campeau\, LPC: Preventing and working with psychedelic crises\, thresholds and safety planning\n\nFurther info on each speaker can be found in their bio below. \nFree for SCC members\, $25 for non-members \n  \nRSVP >> \n  \nDustin Sulak\, D.O. is a traditional osteopathic physician and expert in integrative medicine. His clinical practice in Maine focuses on treating refractory conditions in adults and children. Dr. Sulak is an internationally-renowned expert in medical cannabis\, the author of the first foundational text on its clinical use\, Handbook of Cannabis for Clinicians: Principles and Practice\, and a co-founder of Healer.com\, a medical cannabis education resource. He is a passionate educator and leader in the field of medical cannabis\, and serves on the board of directors of The Society of Cannabis Clinicians. \n  \nSaj Razvi\, LPC is the founder and Director of Education at Psychedelic Somatic Institute. He was a clinical researcher in the MAPS Phase 2 trial of MDMA-assisted psychotherapy. He is faculty at Mind Medicine Australia and formerly taught PTSD studies at the University of Denver. He is the primary developer of the Psychedelic Somatic Interactional Psychotherapy (PSIP) modality which is a next generation non-ordinary state psychotherapy that maximizes the relational and autonomic healing capacity of psychedelic medicine to treat complex\, childhood developmental trauma. His primary focus is to train clinicians to provide legal\, effective psychedelic treatment in their private practice settings utilizing readily accessible medicines such as cannabis and ketamine. Click here to view an actual psychedelic therapy session using PSIP and cannabis. \n  \n  \n  \nRebecca Kronman\, LCSW is a licensed therapist and founder of Plant Parenthood\, a digital and in-person community of parents who use psychedelics. She is also an assisting trainer with Fluence\, a company that trains healthcare practitioners in harm reduction informed psychedelic preparation and integration. At her private practice in Brooklyn\, she works with clients using mindfulness\, experiential techniques and ketamine assisted psychotherapy to address depression\, anxiety and life transitions. She also helps clients prepare for psychedelic experiences\, incorporate insights or cope with challenges post-experience. Selected trainings include Mindfulness Based Stress Reduction\, Mindfulness for Clinicians\, Psychedelics 101 & 102 and Beyond Experience Psychedelic Integration Workshop. Outside of work\, she is a mother of two boys ages 5 and 7. \n  \n  \n  \nMark Braunstein\, DO\, ABPN Matthew trained as a psychotherapist at Naropa University in Transpersonal Counseling Psychology. He has been an Independent Rater with the Multidisciplinary Association for Psychedelic Studies (MAPS) since 2012\, currently supporting Phase 3 MDMA Assisted Psychotherapy studies. Matthew has trained in Ketamine Assisted Psychotherapy with the Ketamine Training Center. He has worked with thousands of suicidal and high acuity clients and is passionate about harm reduction and prevention. Matthew has 12 years clinical experience with individuals with mild to chronic and severe mental illnesses and has a strong ability to remain grounded and support clients in dysregulation\, crisis\, psychosis\, or altered states of consciousness. In addition to developing psychedelic psychotherapy protocols\, he practices ketamine and cannabis-assisted psychotherapy. \n  \n  \n  \n  \nMatthew Campeau\, LPC “Dr. B\,” is a whole health psychiatrist. He completed his residency in general psychiatry and his fellowship in child and adolescent psychiatry in 1997. Shortly thereafter\, he began exploring the use of psychoactive plant-based medicines in the treatment of various psychiatric conditions in both children and adults. With over 22 years of clinical experience\, Dr. B has pioneered a new path in psychiatric care that integrates wilderness programming\, exercise\, diet\, spirituality\, and natural medicines. Dr. B is the medical director for multiple mental health clinics\, including a groundbreaking psychedelic psychotherapy practice in Durango\, Colorado. His plant-based dosing protocols have made him a sought-after medical consultant\, advisor\, and educator. With a focus on expanding access\, awareness\, research\, and safety in the field of psychedelics\, Dr. B champions innovative technology and telemedicine at his company Reconscious Medical. His mission is to create tailored solutions that empower patients to live full\, happy\, unencumbered lives.
URL:https://www.cannabisclinicians.org/event/cannabis-psychedelics-webinar/
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2021/10/Cannabis-Psychedelic-Medicine-Webinar-web-banner.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20211208T090000
DTEND;TZID=America/Los_Angeles:20211208T103000
DTSTAMP:20260607T072512
CREATED:20210929T135028Z
LAST-MODIFIED:20211206T085212Z
UID:10000094-1638954000-1638959400@www.cannabisclinicians.org
SUMMARY:SCC International Veterinary Alliance Webinar: Dosing & Administration
DESCRIPTION:9-10:30am PST / 11am-12:30pm CST / 12-1:30pm EST / 5-6:30pm BST  \nJoin an international lineup of experts exploring how veterinarians approach the philosophy of dosing and the main considerations when creating a treatment plan for animal patients. The SCC International Veterinary Alliance Webinar is open to anyone interested in the applications of cannabis in veterinary practice. \nTopic:\nCannabis Dosing and Administration Strategies in Veterinary Medicine \nSpeakers (bios below):\n\nSantiago Acosta\, DVM – (Colombia)\nRafael Ricardo Santisteban-Arenas\, DVM (Colombia)\nErik Almeida\, DVM (Brazil)\nTrina Hazzah\, DVM (USA)\nGary Richter\, DVM (USA)\nConny Mosley\, DVM (Canada)\nSarah Silcox\, DVM (Canada)\n\nFree for SCC members\, $10 for non-members \n  \nRSVP >> \n  \n Trina Hazzah\, DVM was born and raised in Washington DC. She attended Tuskegee University School of Veterinary Medicine where she earned her Doctor of Veterinary Medicine in 2006. She has also completed the requirements to be a Certified Veterinary Chinese Herbalist from the Chi Institute of Traditional Chinese Veterinary Medicine. Dr. Hazzah developed an interest in cannabis medicine during her quest for finding effective integrative approaches for veterinary cancer patients. She has spent the last half a decade reading through available literature\, attending multiple cannabis conferences and symposiums\, while also learning from cannabis physicians.  She is is the president and co-founder of the Veterinary Cannabis Society\, which is the first US-based non-profit\, 501(c)(3) organization building awareness of cannabis as medicine for pets. \n  \n  \n  \n  \nDr. Gary Richter has been practicing veterinary medicine in the SF Bay Area since 1998. He is certified in acupuncture\, chiropractic\, and Western herbology. Dr. Richter’s practice focuses on the benefits of conventional and holistic treatment methods for the preventative and therapeutic care of pets as well as educating professionals and pet owners on the benefits of integrative care. Dr. Richter was named Holistic Veterinarian of the Year for 2019 by the American Holistic Veterinary Medical Association\, is currently the President of the American College of Veterinary Botanical Medicine\, and is a founding member of the Veterinary Cannabis Society. \n  \n  \n  \n \n\nSantiago Acosta Colmenares\, DVM is the CEO of ENDOVET and the President of the Latin American Veterinary Medicine Association. He is currently a professor of medicinal cannabis at the National University of Colombia\, University of Rosario\, and University of Caldas. He is a member Society of Cannabis Clinicians (SCC) and Canadian Association of Veterinary Cannabinoid Medicine (CAVCM). He is also an advisor to the Colombian Agricultural Institute on issues related to medicinal cannabis in veterinary medicine. He is an international speaker on Medicinal Cannabis and entheogens in veterinary medicine and also designs cannabis-based products.\n \n \n \n \n \n \n  \n Dr. Sarah Silcox is a pioneer in the world of veterinary cannabis use and is one of the founding directors and the current President of the Canadian Association of Veterinary Cannabinoid Medicine. An OVC ‘97 grad\, she is a small animal veterinarian with over 20 years of clinical experience. Dr. Silcox has been active in general\, locum\, and emergency practice\, founded her region’s first integrative medicine practice\, and is currently operating her region’s first veterinary practice dedicated solely to palliative\, hospice\, and end-of-life care for pets. A passionate advocate for the veterinary use of cannabis and cannabinoid medicine\, her interest in the potential benefits of medical cannabis for pets reaches back several years. With changes in legislation that legalized cannabis in Canada\, she is grateful to now be able to guide her clients on the responsible use of cannabis for treating their pets and has seen numerous patients that have benefited from the therapeutic effects of this amazing plant.\n \n \n \n \n \nDr. Erik Amazonas is an Associated Professor of Veterinary Medicine at the Federal University of Santa Catarina. Dr. Amazonas was the first to include classes of endocannabinology in a veterinary school in Brazil in 2018. Dr. Erik collaborates with several universities and non profit organizations in Brazil and worldwide and is a member of the Veterinary Cannabis Society.\n \n \n \n  \n  \n \n  \n Dr. Cornelia (Conny) Mosley is a boarded anesthesiologist working as a Veterinary Consultant in Orthopedic Health and Pain for Elanco Canada as well as providing care for chronic pain patients in her Integrative Veterinary Pain Clinic at VCA Canada\, 404 Veterinary Emergency and Referral Hospital in Newmarket\, north of Toronto. She has a strong interest in pain management\, in particular in the integrative and collaborative approaches to pain relief. Conny is certified in veterinary acupuncture. Dr. Mosley is also the founding director and vice president of the Canadian Association of Veterinary Cannabinoid Medicine\, an organization that helps understand\, educate and collaborate in research in cannabinoid medicine and it’s role in veterinary medicine. \n  \n  \n Rafael Ricardo Santisteban-Arenas\, DVM is a DVM and MSc from Universidad de Caldas en Colombia. He is currently an Assistant Professor Institución Universitaria Visión de las Américas\, Pereira and Medical Coordinator Veterinary Clinic Institución Universitaria Visión de las Américas\, Pereira. He is also a Veterinary Advisor for Khiron Life Sciences Corp and Member of Red Cannabis Medicinal Veterinaria\, Colombia. His research publications include chronic gastrointestinal conditions\, cannabinoid therapy in small animals\, infectious diseases and palliative care.
URL:https://www.cannabisclinicians.org/event/scc-international-veterinary-alliance-webinar-dosing-administration/
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2021/09/Veterinary-Alliance-Webinar-Banner.jpg
END:VEVENT
END:VCALENDAR